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Background:TSG-6 (TNF-stimulated gene-6)-dependent transfer of heavy chains from inter--inhibitor onto hyaluronan
is critical for ovulation.
Results: A calcium ion and chelating glutamate within TSG-6 mediate formation of the covalent heavy chain-TSG-6
intermediate.
Conclusion: TSG-6 transferase activity rather than hyaluronan binding drives cumulus expansion.
Significance: The role of metal ions in hyaluronan-heavy chain formation has been determined.
Thematrix polysaccharide hyaluronan (HA) has a critical role
in the expansion of the cumulus cell-oocyte complex (COC), a
process that is necessary for ovulation and fertilization in most
mammals. Hyaluronan is organized into a cross-linked network
by the cooperative action of three proteins, inter--inhibitor
(II), pentraxin-3, andTNF-stimulated gene-6 (TSG-6), driving
the expansion of the COC and providing the cumulus matrix
with its required viscoelastic properties. Although it is known
that matrix stabilization involves the TSG-6-mediated transfer
of II heavy chains (HCs) onto hyaluronan (to form covalent
HCHA complexes that are cross-linked by pentraxin-3) and
that this occurs via the formation of covalent HCTSG-6 inter-
mediates, the underlying molecular mechanisms are not well
understood. Here, we have determined the tertiary structure of
the CUBmodule from human TSG-6, identifying a calcium ion-
binding site and chelating glutamic acid residue that mediate
the formation of HCTSG-6. This occurs via an initial metal ion-
dependent, non-covalent, interaction between TSG-6 and HCs
that also requires the presence of an HC-associated magnesium
ion. In addition, we have found that the well characterized hya-
luronan-binding site in the TSG-6 Link module is not used for
recognition during transfer of HCs onto HA. Analysis of TSG-6
mutants (with impaired transferase and/or hyaluronan-binding
functions) revealed that although the TSG-6-mediated forma-
tionofHCHAcomplexes is essential for the expansionofmouse
COCs in vitro, the hyaluronan-binding function of TSG-6 does
not play a major role in the stabilization of the murine cumulus
matrix.
In the majority of mammals, ovulation is immediately pre-
ceded by the formation of a viscoelastic extracellular matrix by
the cumulus cells that surround the oocyte (1, 2). The produc-
tion of this matrix drives the expansion of the cumulus cell-
oocyte complex (COC),3 protecting the COC during its expul-
sion from the follicle, allowing its pickup and transport by the
oviduct and providing a large surface area that facilitates sperm
capture in vivo (3–5). The high molecular weight polysaccha-
ride hyaluronan (HA) is a key structural component of the
cumulus matrix; this non-sulfated glycosaminoglycan, com-
posed entirely of repeating disaccharides of glucuronic acid and
N-acetyl glucosamine, is organized into a cross-linked network
during cumulus expansion, providing stability and the required
mechanical properties of the COC (6–8). There is compelling
evidence that this HA-rich matrix is stabilized through the
cooperative action of inter--inhibitor (II), pentraxin-3, and
TSG-6 (TNF-stimulated gene-6) (9–15); all three of these gly-* This work was supported by Arthritis Research Campaign Grants 14871,
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coproteins have been implicated as being essential, in the
mouse at least (2), because functional depletion/inhibition of
any one of them greatly impairs COC expansion, leading to
female infertility. Recent biophysical analysis has also demon-
strated that human II, pentraxin-3, and TSG-6 are sufficient
for the formation of a cross-linked matrix in model HA films
(16). Most of these components (i.e. HA, pentraxin-3, and
TSG-6) are produced by the cumulus cells in response to the
gonadotropin surge (11, 15, 17, 18), which also leads to the
altered permeability of the blood-follicle barrier, allowing II to
enter from the blood (1).
II is composed of three protein chains (bikinun, heavy chain
1 (HC1), and HC2) that are held together covalently by a chon-
droitin sulfate (CS) chain (19–21); the CS, which contains both
sulfated and non-sulfated regions (22–24), is attached to
bikunin via a standard glycosaminoglycan linkage, and the
HCs are attached to this proteoglycan via ester bonds
between their C-terminal aspartic acid residues and C6-hy-
droxylates of N-acetyl galactosamine sugars of the CS chain
(25). Importantly, both HC1 and HC2 of II can be cova-
lently transferred onto the C6-hydroxyls of the N-acetyl glu-
cosamine sugars in HA to form HCHA, which are some-
times referred to as SHAP-HA (26–29). The formation of
these complexes, in which HA is probably decorated with
multiple HCs (30), is essential for ovulation/fertilization;
deletion of the bikunin gene, which abolishes the biosynthe-
sis of II and consequently the production of HCHA, leads
to a lack of cumulus expansion and greatly impaired fertility
in mice (9, 10).
Deletion of pentraxin-3 also impairs the incorporation ofHA
into the COC matrix but does not affect the formation of
HCHA (15). It is likely that pentraxin-3, which has no inherent
HA-binding activity (15, 16), contributes to cross-linking of
HCHA complexes via interactions with the attached HC (31);
pentraxin-3 is an octameric protein composed of eight identical
subunits (connected by disulfide bonds) through which it may
bind simultaneously to multiple HCs linking HCHA com-
plexes together (16, 32–34).
TSG-6 is a 35-kDa (single chain) protein composedmainly of
contiguous Link and CUB modules that are flanked by N- and
C-terminal sequences of 18 and 29 amino acids, respectively
(35, 36). It has been found to be crucial in the formation of
HCHA, and the COCs from TSG-6/ mice (that failed to
expand) contained no detectable HCHA complexes (12).
TSG-6 was shown to play a direct role in the transfer of HCs
from II onto HA via the formation of covalent intermediates
(HC1TSG-6 and HC2TSG-6) and act as a catalyst in this pro-
cess (37). These HCTSG-6 complexes (37, 38) are linked
through ester bonds between Ser-28 of TSG-6 (in its N-termi-
nal region) and the C-terminal aspartates of the HCs men-
tioned above (39); free HCs are unable to form these complexes
with TSG-6 (or its individual domains) because this requires
the presence of ester bonds connecting HCs to the CS chain
of bikunin that are made during the biosynthesis of II (see
Ref. 37).
Thus, it is clear that the formation of HCHA involves two
sequential transesterification reactions (37, 39, 40). However,
beyond this, the molecular bases of HCTSG-6 complex forma-
tion and HC transfer onto HA are not particularly well under-
stood. It is known that these processes are divalent cation-de-
pendent, but there is a lack of consensus on the identity ofmetal
ions required and their locations within the II and TSG-6 pro-
teins (37, 40–42); the TSG-6 CUB module has been predicted
to contain anMg2-binding site based on homology with other
CUB domains (37). Furthermore, it is far from clear how II
and TSG-6 interact leading up to the formation of the
HCTSG-6 intermediates (40, 43, 44) or indeed how HA is
recognized by these complexes during HC transfer (45). For
example, full-length TSG-6 has been shown to interact (non-
covalently) with bikuninCS as well as HC1 and HC2 (40, 44,
46). The former is probably mediated (at least in part)
through the binding of the Link module to the CS moiety
(40), consistent with its ability to bind to CS and the non-
sulfated glycosaminoglycan chondroitin (45, 47); however,
the region of TSG-6 that interacts with the HCs is not
known. The TSG-6 Link module, for which NMR and x-ray
structures are determined (48–50), also mediates the inter-
action of TSG-6 with HA (see Ref. 51). However, the well
characterized HA-binding groove in TSG-6 (45, 49, 52) may
not be used for HA recognition by the HCTSG-6 complexes
during HC transfer (45).
TSG-6 also binds directly to pentraxin-3 using a site on the
Linkmodule that does not overlap with its HA-binding surface,
leading to the hypothesis that pentraxin-3-TSG-6 complexes
could cross-linkHAchains (15). Although this is apparently not
the case for full-lengthTSG-6 (16), it has not been ruled out that
TSG-6 canplay a direct structural role in the organization of the
cumulus matrix via its HA-binding properties (see Refs. 12, 13,
51, 53, and 54).
It is worthy of mention that HCHA complexes are also
formed in contexts other than ovulation and that, at present,
TSG-6 is the only known transferase that can mediate their
production.Most likely this is an ancient process in vertebrates,
which predates cumulus expansion (55). HCHA complexes
formwherever II, TSG-6, andHA come into contact (see Refs.
37 and 55). Given that in most tissues, TSG-6 is only expressed
during inflammation (36, 56), it is not surprising that HCHA
complexes are most often associated with inflammatory pro-
cesses and disease (30, 57–60). Current evidence suggests
that decoration of HA with HCs has an important role in
modulating cell adhesion and cell phenotype (44, 61, 62) and
that certain HCHA complexes can mediate protective
effects (62–66). The precise activity of HCHA complexes
(and whether they are protective or pathological) will prob-
ably depend on their exact composition (e.g. number and
type of HCs, size of HA, etc.) and the identity of other asso-
ciated structural/signaling molecules (44).
Here we report the tertiary structure of the CUB module
from human TSG-6 and the determination of its role in HC
transfer. We have also clarified which metal ions are required
for HCTSG-6 complex formation, identifying divalent cation-
binding sites in both II and TSG-6 thatmediate an initial non-
covalent interaction. Furthermore, we have demonstrated that
it is the HC transferase activity of TSG-6, rather than HA bind-
ing, that is crucial for murine COC expansion.
Mechanism of TSG-6-mediated HCHA Formation
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Experimental Procedures
Production of Recombinant Proteins and HA Oligosacchar-
ides—Full-length human TSG-6 (rhTSG-6) was expressed in
Drosophila S2 cells and purified as before (67). The Link_TSG6
and CUB_C (Gln-144 allotype) constructs of human TSG-6
(residues 36–133 and 128–277, respectively, of the preprotein
(35)) were expressed in Escherichia coli, refolded, and purified
as described previously (68–70). Recombinant human heavy
chain 1 (rHC1) was produced as detailed previously (44).Muta-
tions in CUB_C and rHC1 were introduced into the expression
vectors by QuikChange mutagenesis (Agilent Technologies,
Cheadle, UK), essentially following the manufacturer’s re-
commendations. Mutations in rhTSG-6 were introduced into
the expression vector using the Transformer site-directed
mutagenesis kit (Clontech, Palo Alto, CA), following the man-
ufacturer’s guidelines (see Refs. 67 and 71). HA 14-mers (HA14)
and biotinylated HA decasaccharide (bHA10) were made as
described previously (in Refs. 72 and 73, respectively).
Crystallization of CUB_CandDetermination of CUBModule
Structure—Initial crystallization conditions were obtained
using the SM1 screen fromQiagen (Manchester, UK), using the
sitting drop vapor diffusion technique at room temperature. A
focused screen around these initial conditions yielded 30-m
crystals with a tetragonal bipyramidal morphology. Seeds
derived from these crystals were streaked into drops containing
1 l of 5 mg/ml CUB_Cmixed with 1 l of mother liquor com-
posed of 100 mM HEPES, pH 7.5, 22% (v/v) PEG 1000, and 200
mM MgSO4, yielding larger crystals.
Data to 2.3 Å were collected from 250  250  250-m
crystals, cryoprotected using Paratone-N oil (Molecular Di-
mensions, Cambridge, UK), on a Rigaku-007 rotating anode
x-ray generator and an R-axis IV image plate detector. The data
were indexed and integrated using the Mosflm program (74).
Point group analysis using the POINTLESS program (75) indi-
cated either P43212 or P41212 symmetry. Data were scaled and
reduced using the Scala andTruncate programs (76).Matthews
coefficient analysis indicated the presence of one monomer in
the asymmetric unit. Initial phases were obtained by molecular
replacement using the Molrep program (77), and a homology
model of CUB, based upon MAp19 coordinates (Protein Data
Bank code 1SZB) (78), was generated using the PHYRE server
(79). The molecular replacement solution confirmed P43212
symmetry. This model was then refined to convergence with
alternative rounds of restrained maximum likelihood refine-
ment using REFMAC (80) and manual rebuilding using the
Coot program (81). Final processing statistics are shown in
Table 1. Only the CUB module (residues 128–249) was visible
in the crystal structure with no electron density seen for the last
28 amino acid residues, although this region was verified as
present in the crystals by SDS-PAGE (not shown). The last res-
idue observed in the electron density is Pro-249, which pro-
trudes into a large solvent channel; this might allow the C-ter-
minal region to adopt a range of conformations, thus rendering
it essentially invisible to crystallography.
HCTSG-6 and HCHA Complex Formation—The effects of
rhTSG-6 mutagenesis on the formation of HCTSG-6 and
HCHA complexes were determined using the assays described
previously (37, 45). Briefly, in the standard experiment, 80
g/ml (2.7 M) rhTSG-6 and 320 g/ml (1.8 M) II, purified
from human serum (19, 82), were incubated together in 20 mM
HEPES, pH 7.5, 150 mMNaCl, 5 mMMgCl2 in a total volume of
25 l for 2 h at 4 °C; this was done either in the absence (“com-
plex formation”) or presence (“HC transfer”) of 40 g/ml HA14
or bHA10. In complex formation experiments where EGTA/
Ca2 was also added, only 1 mM MgCl2 was used, which is
sufficient for full activity (37); when the pH was varied, sodium
acetate (pH 4.0 or 5.0) orMES (pH 6.0 or 6.5) were used instead
of HEPES (pH 7.0, 7.5, or 8.0). Samples (7.5 l of reaction mix-
ture) were then run on 10% (v/v) Tris-Tricine/SDS-polyacryl-
amide gels after reduction with 5% (v/v) -mercaptoethanol in
SDS protein sample buffer (5 min at 100 °C) and stained with
Coomassie Blue. Alternatively, HCTSG-6 complexes were
visualized byWestern blotting using a rabbit anti-human poly-
clonal antibody (RAH-1) raised against TSG-6 (see Ref. 37);
HCbHA10 complexes (16) were detected with streptavidin-
conjugated Alexa 488 (Invitrogen) on a LI-COR Odyssey sys-
tem, and band intensities were quantified by ImageJ software.
All gels and blots shown are representative of at least three
independent experiments.
Surface Plasmon Resonance—Surface plasmon resonance
(SPR) experiments were carried out using a BiaCore 3000 or
T-200 (GE Healthcare). CUB_C proteins (WT or E183S) and
WT rhTSG-6 were coupled to a BiaCore CM5 chip (to give
1000 response units) via standard amine-coupling chemistry
(EDC-NHS); here CUB_C (50 g/ml) and WT rhTSG-6 (10
g/ml) were immobilized in 10mM sodium acetate, pH 4.0, and
10 mM MES, pH 6.0, respectively, at a flow rate of 10 l/min.
Then rHC1 (WT or D298A) was injected over the chip surface
(30 l/min) at a range of concentrations in 20 mM HEPES, 150
mMNaCl, 0.05% (v/v) Tween 20, pH 7.4 (HBS-T), with/without
EDTA (see Table 2); as described above, in the absence of
EDTA (“standard” buffer conditions) the “as purified” CUB_C
proteins contain Ca2 ions. In other experiments, rHC1 (WT
or D298A) was immobilized on a C1 chip (as described in Ref.
44; i.e. at 10 g/ml in 10 mM sodium acetate, pH 5.5, at 10
l/min), and Link_TSG6 was flowed over at a range of concen-
trations in HBS-T. All SPR experiments were performed in
duplicate or triplicate, and numerical values (mean  S.E. in
Table 2) were determined frommulticycle kinetics, where data
were fitted to a 1:1 Langmuir model using the BiaEval T-200
software; fitting of data to a bivalent analyte model did not
improve any of the fits.
Intrinsic Fluorescence—CUB_C protein was incubated in 20
mM HEPES-HCl, 150 mM NaCl, pH 7.4 (HBS) with 10 mM
EDTA and 10mM EGTA before buffer exchange into HBS with
2MEDTA and 2MEGTA (to removemetal ions and prevent
metal ion scavenging, respectively). Intrinsic fluorescence spec-
tra were recorded on 3 M CUB_C in the absence/presence of
20Mmetal ions on a Jasco (Dunmow, UK) FP750 spectrofluo-
rometer compared with “as purified” CUB_C in HBS alone; the
CaCl2, MgCl2, and MnCl2 used (Ultrapure, Sigma-Aldrich)
were ultrahigh purity (99.999% (w/w) trace metal basis). The
excitation wavelength was set at 280 nm, and emission spectra
were recorded between 300 and 400 nm with excitation/emis-
Mechanism of TSG-6-mediated HCHA Formation
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sion wavelength slit widths of 4 nm. All measurements were
performed in triplicate and averaged after buffer subtraction.
Additionally, the fluorescent intensity of the tryptophan
peak at 330 nm was determined (as above) for 2 M CUB_C in
HBS (containing 2 M EGTA as a metal ion scavenger) at a
range of CaCl2 concentrations (0–40 M). Data were fitted by
non-linear regression to a one-sitemodel; theCa2 ion concen-
trations used in the fittingwere not corrected to take account of
the added EGTA.
Nuclear Magnetic Resonance Spectroscopy—One-dimen-
sional 1H NMR spectra were collected on 0.1 mM CUB_C (WT
or E183S) in PBS (pH 6.5) using a Bruker (Coventry, UK)
Avance 600-MHz spectrometer (equipped with a 1H-13C/15N
TXI cryoprobe with z-gradients) at 25 °C in the absence (“as
purified”) or presence of EGTA (5 mM or as indicated) and/or
CaCl2 (10 mM).
HA-binding Assay—The HA-binding activity of rhTSG-6
(WT and mutants) was determined using a microtiter-based
assay employing biotinylated HA as described previously (83).
Briefly, TSG-6 proteins were immobilized at various concen-
trations onMaxisorb plates (Nunc, Fisher, Loughborough, UK)
and incubated with biotinylated HA (12.5 ng/well) in 50 mM
sodium acetate, 100 mM NaCl, 0.05% (v/v) Tween 20, pH 6.0;
bound biotinylated HA was detected with ExtraAvidin alkaline
phosphatase, and plates were developed using disodium p-ni-
trophenyl phosphate. All absorbance measurements (A405 nm)
were corrected by subtracting values from uncoated control
wells. Mean data  S.E. were derived from two independent
experiments performed in quadruplicate (n 8).
COC Expansion Assays—Experiments involving animals
were approved by the institutional animal care anduse commit-
tee and carried out according to the Italian and European rules
(D.L. 116/92; EEC Council Directive 86/609; European Direc-
tive 2010/63/EU). COC isolation, culture and in vitro expansion
were carried out essentially as described before (12, 84). Briefly,
adult BALB/c femalemice deficient for TSG-6 (12) or wild type
(TSG-6/) controls were injected with 5 IU of pregnantmares
serum gonadotropin (Folligon, MSD Italia, Rome, Italy) and
sacrificed 44–48 h later. COCs were isolated from large antral
follicles in Eagle’s minimum essential medium (Gibco Invitro-
gen, Milan, Italy) containing 25 mM HEPES, 0.1% (w/v) BSA
(Sigma-Aldrich), and 50 ng/ml gentamycin (Gibco Invitrogen).
Compact COCs were cultured, under mineral oil (Sigma-Al-
drich), in 20-l droplets of Eagle’s minimum essential medium
supplemented with 5% (w/v) fetal bovine serum (Gibco Invit-
rogen), 3 mM glutamine (Sigma-Aldrich), 0.3 mM sodium pyru-
vate (Sigma-Aldrich), and 50 ng/ml gentamycin in the presence
of 3 ng/ml EGF (Life Technologies), at 37 °C with 5% (v/v) CO2
in humidified air for 16 h. TSG-6 proteins were added to the
medium at the beginning of culture, at the concentrations indi-
cated in “Results.”
Results
Structure of TSG-6 CUBModule Reveals a Ca2 Ion-binding
Site—To test our prediction that a functionally importantmetal
ion-binding site is present within human TSG-6 (37, 85), we
determined the crystal structure of its CUB module to 2.3 Å
(Fig. 1A andTable 1); this was based on the crystallization of the
human CUB_C domain (i.e. the CUBmodule and the C-termi-
nal 29 amino acid residues), which we had previously shown by
NMR spectroscopy to be folded (70). This revealed it to have a
classical CUB-type jelly roll fold, with a greater degree of simi-
larity to the metal ion-binding subclass of CUB domains (C1s,
MASPs) compared with the non-metal ion-binding spermad-
hesins (86), and, consistent with this, it contained a divalent
cation at the site we had predicted (Fig. 1).
The metal ion-binding site in the TSG-6 CUB module con-
sists of seven oxygen ligands with pentagonal bipyramidal
coordination geometry. This is composed of the main chain
carbonyl groups of Ser-234 and Val-235, monodenate coordi-
FIGURE 1. Structure of TSG-6 CUB module. A, cartoon representation of the crystal structure of the CUB module from human TSG-6, colored from blue (N
terminus) to red (C-terminus) with the calcium ion in cyan. B, detailed view of the calcium ion-binding site, with ligating residues highlighted. C, side view of
TSG-6 CUB module, colored as in A, showing the positions of side chains for Trp-163, Ile-165, Leu-230, and Ile-242. Figures were created using UCSF Chimera.
Mechanism of TSG-6-mediated HCHA Formation
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nation with side chain carboxylate groups of Glu-183 and Asp-
232, and bidentate coordination with the carboxylate of Asp-
191 and a buried water molecule (Fig. 1B), an arrangement
highly suggestive of Ca2 (or perhaps Mn2). This binding site
is very similar to that found in other CUB modules (78, 87),
which can be capable of accommodating both Mg2 and Ca2
ions. Based on our previous finding that the formation of
HCTSG-6 complexes was dependent on the presence of mag-
nesium ions, we had expected to find a Mg2 rather than Ca2
at this site (37). However, nomagnesium ion-binding sites were
discovered during the refinement and analysis of the TSG-6
CUBmodule structure, despite the presence of 200mMMgSO4
in the crystallization conditions. Analysis of the structure using
the “WASP” server (88) confirmed the absence of Mg2-bind-
ing sites in the CUBmodule structure and confirmed that none
of the modeled water molecules were magnesium ions.
Intrinsic fluorescence spectroscopy showed that the
addition of 20 M CaCl2 to metal ion-free CUB_C (3 M) in
physiological salt/pHconditions results in a significant quench-
ing of tryptophan fluorescence at 330 nm, leading to tyrosine
fluorescence becoming visible at 305 nm (Fig. 2A); because
there is only one tryptophan inCUB_C, it can be concluded that
Trp-163 (Fig. 1C) is sensitive to Ca2 ion binding through an
altered conformation and/or altered solvent accessibility of the
CUBmodule.Whereas the addition ofMgCl2 has essentially no
effect on the intrinsic fluorescence spectrum, it can be seen that
Mn2 binds to CUB_C, but the observed change in fluores-
cence is less pronounced than with CaCl2, indicative of weaker
(or differential) binding (Fig. 2A). Non-linear regression analy-
sis of the tryptophan intensities for 2 M CUB_C at a range of
added CaCl2 concentrations (0–40 M) determined a binding
affinity of 1.6 0.6M for the interaction of CUB_Cwith Ca2
ions (Fig. 2B). In Fig. 2A, the finding that the spectra in the
presence ofCa2were essentially identical to those collected on
the “as purified” CUB_C domain (with no added metal ions or
chelators) indicates that following purification, the protein
already contains bound calcium.
To further explore calcium ion binding, we carried out one-
dimensional 1H NMR measurements on CUB_C in different
concentrations of EGTA and calcium (Fig. 3). Upon the addi-
tion of EGTA to “as purified” CUB_C, there were no major
changes in the NMR spectrum, with only subtle alterations
observed in the position/intensity of high field-shifted methyl
peaks, which were reversed upon the addition of excess Ca2
ions. Calculations of 1H chemical shifts from the CUB module
crystal structure using ShiftX (89) predict that the most high
field-shifted resonances correspond to the methyl protons of
Ile-165, Leu-230, and Ile-242; of these, Leu-230 is in close prox-
imity to aromatic residues in the vicinity of the Ca2 ion-bind-
ing site, and Ile-165 and Ile-242 are close to Trp-163 that is
affected by Ca2 binding (see Fig. 1C). Overall, these data pro-
vide evidence that Ca2 is not required for stabilization of the
TSG-6 CUB module fold but rather plays a role in the local
organization of loops surrounding the calcium ion-binding site
(see Fig. 1, A and B) and perhaps also has some effect on the
stability of the protein core. The similarity of the NMR spec-
trum for the “as purified” protein to that for CUB_C in the
presence of excess Ca2 ions (Fig. 3) demonstrates that follow-
ing purification, the CUB_C protein is fully calcium-bound.
Glu-183 in the CUB Ca2 Ion-binding Site Is Involved in
HCTSG-6 Complex Formation—Two residues of TSG-6
involved in chelating calcium (Glu-183 and Asp-232; Fig. 1B)
TABLE 1
Crystallographic data and refinement statistics
Parameters Values
Source CuK
Space group P43212
Unit cell parameters a b 56.93 Å, c 112.57 Å,
   90°
Resolution range (Å) 40–2.3 (2.42–2.35)a
No. of unique reflections 8616
Redundancy 5.4 (2.5)
I/I 8.5 (1.3)
Completeness (%) 98.7 (92.1)
R(p.i.m.) (%) 4.9 (51.8)
RCryst/Rfree (%) 19.1/22.8
Root mean square deviation, bonds (Å)/
angles (degrees)
0.007/1.113
Average ADPb protein/solvent 13.6/39.6
Ramachandran plot (%)
Most favored 94.9
Additionally allowed 3.4
Outliers 1.7
aNumbers in parentheses represent the values for the highest resolution shell.
b Atomic displacement parameter.
FIGURE 2. The TSG-6 CUB_C domain binds to calcium and manganese
ions. A, intrinsic fluorescence spectra of CUB_C in HBS (As purified) or HBS
with 2 M EDTA, 2 M EGTA in the absence (no M2) and presence of 20 M
divalent cations; spectra are averaged from three independent experiments
after buffer subtraction. B, tryptophan fluorescence intensity values for 2 M
CUB_C (in HBS, 2M EGTA) were determined (in triplicate) in the presence of
0–40 M CaCl2 without subtraction of background fluorescence; these data
(mean S.D.) were plotted against Ca2 ion concentration and analyzed by
non-linear regression to a one-site bindingmodel (using the formula, fluores-
cence intensity  Rmin[Ca
2]/KD[Ca
2] in GraphPad Prism), yielding a KD
value of 1.6 0.6 M. No errors are shown for the data point at 15 M Ca2
because these are within the range covered by the data symbol.
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were mutated in order to determine the role of the Ca2 ion-
binding site in the formation of HCTSG-6 complexes. E183S
and D232A mutants, made in the context of the recombinant
full-length protein (rhTSG-6), were found to have greatly
diminished ability to form HCTSG-6 compared with the wild-
type (WT) protein based on visualization of this complex on
SDS-PAGE (Fig. 4A; data not shown forAsp-232);Western blot
analysis revealed a low level of activity for E183S (see lanes 2
and 6 in Fig. 4A forWTandE183S, respectively, under standard
assay conditions).
Analysis of equivalent mutations in the CUB_C domain by
intrinsic fluorescence spectroscopy revealed that alteration of
Asp-232 to alanine compromises the folding of the protein
(explaining its lack of activity), whereas the E183S mutant
remains folded (data not shown). Analysis by NMR confirmed
that E183S is folded (Fig. 4B). It also demonstrated that
although the E183S andWT proteins have very similar spectra
in the presence of EGTA, E183S in the absence of any added
EGTA or added Ca2 (i.e. “as purified”) is amixture of calcium-
bound and calcium-free material. This is indicative of reduced
Ca2 ion-binding affinity for E183S compared with WT
CUB_C, which is not surprising given the direct role of Glu-183
in calcium chelation (Fig. 1B). Consistent with this, EGTA
treatment effectively abolished HCTSG-6 complex formation
in E183S, whereas WT rhTSG-6 retained some activity (Fig.
4A). Interestingly, in the presence of excess Ca2 (10 mM), the
high field region of theNMRspectrum for E183S closely resem-
bles that of the WT CUB_C domain (Fig. 4B), revealing that
under these conditions, it can become fully calcium-bound and
attain a fold essentially identical toWT. However, in functional
assays, the addition of calcium ions only increased the amount
of HCTSG-6 product formed for E183S to5% of that seen for
the WT protein (estimated from SDS-PAGE band intensity;
Fig. 4A, lanes 8 and 9). These findings strongly suggest that the
side chain of Glu-183 plays an important role in the formation
of the covalent complex between TSG-6 and HC that is only
partly dependent on its chelation of Ca2.
Both CUB_C and Link Domains of TSG-6 Interact with II
HCs—Given the observation that the activity of E183S can be
partially restoredwith excessCa2 (Fig. 4A), we reasoned that it
is unlikely that this residue has a direct catalytic role in
HCTSG-6 formation but rather that it might participate in
substrate (i.e. heavy chain) recognition. In order to test this, we
looked at binding of CUB_C to rHC1 using SPR. As shown in
Fig. 5A, WT CUB_C interacted with rHC1 in the presence of
Ca2 (KD  2.1 nM; see Table 2) but did not bind in EDTA; in
Fig. 5, pairs of sensorgrams are illustrated at a single common
analyte concentration (i.e. for the purposes of easy compari-
son), where the full SPR data sets are provided in Fig. 6, A–E.
Importantly, the E183Smutant had greatly impaired binding to
rHC1 (Fig. 5B), providing evidence that this amino acid residue
FIGURE 3.NMR spectra ofWT CUB_C in the absence/presence of calcium.
One-dimensional 1H NMR spectra were collected for WT CUB_C in the
absence (As purified) or presence of added Ca2 ions and/or EGTA. The black
arrowsdenote the positions of high field-shiftedmethyl protons that are con-
sistentwith aWT fold, where these are perturbed (gray arrows) upon removal
of calcium.
FIGURE 4. Structural and functional analyses of WT and E183S TSG-6 in
the absence/presence of calcium. A, SDS-PAGE (top) andWestern blot (bot-
tom) analyses reveal that E183Smutation severely diminishes HCTSG-6 com-
plex formation activity of rhTSG-6 and the production of HCbikunin, which is
a by-product of the reaction (see Ref. 37); the arrowhead indicates the faint
HCTSG-6 band generatedwith the E183Smutant of TSG-6 in the presence of
added Ca2. The gel/blot shown is representative of three independent
experiments. B, one-dimensional 1H NMR spectra of WT and E183S CUB_C in
theabsenceorpresenceof addedCa2 ions (10mM)or EGTA (5mM). Theblack
and gray arrows show high field-shifted methyl protons as described in the
legend to Fig. 3; the spectrum for the “as purified” E183S contains amixture of
these resonances, indicating that in thismutant, the Ca2-binding site is only
partially occupied with metal ions.
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FIGURE5.Metal ion-dependent interactionofTSG-6with II heavychains ismediatedby itsCUB_Cdomain.A–D, comparisonof SPR sensorgrams for the
interactions of HCs with TSG-6 (WT and mutant proteins in the absence/presence of metal ions); full SPR data sets are provided in Fig. 6 with derived mean
numerical values shown in Table 2. A, SPR sensorgrams for interactions of immobilized CUB_C (as purified; i.e. containing Ca2) with WT rHC1 (20 nM) in the
absence or presence of 0.5 mM EDTA. B, SPR sensorgrams for interactions of immobilized CUB_C (WT or E183S) with 50 nM rHC1. C, SPR sensorgrams for
interactions of immobilized rHC1 (WT or D298A) with 200 nM Link_TSG6; the concentration of rHC1 was 50 nM compared with 20 nM in A. D, SPR sensorgrams
for interactions of immobilized rHC1 (WT) with Link_TSG6 and immobilized rhTSG-6 with rHC1 (D298A); the concentration of Link_TSG6 is 100 nM compared
with 200 nM in C. RU, response units.
TABLE 2
Surface plasmon resonance analyses and parameters
a,b All values (mean S.E.) are based on multicycle kinetics from experiments performed in duplicate (a) or triplicate (b) (analyte at 0–30 nM and 0–300 nM, respectively).
c Experiments performed at a single concentration (20 nM) in triplicate.
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does make a contribution to the non-covalent interaction
between TSG-6 and HCs, which is believed to precede forma-
tion of the covalent HCTSG-6 complex (40, 44). Furthermore,
we found that a D298Amutation in the context of rHC1, which
forms part of a conservedMIDAS site (37) and abolishes Mg2
ion binding within the HC1 von Willebrand factor A domain
(i.e. based on x-ray crystallography of WT and D298A mutant
of rHC1),4 is unable to bind CUB_C (Table 2). This strongly
suggests that metal ion-binding sites in both the CUB module
and von Willebrand factor A domains contribute to the inter-
action between TSG-6 and HCs.
Full-length TSG-6 has been shown to be able to bind non-
covalently toHC1 andHC2 in ametal ion-independentmanner
(44), which is inconsistent with the above analysis. Therefore,
wereasonedthatanother regionofTSG-6mightalsocontribute to
the binding to HCs. SPR with the Link module of TSG-6 (Link-
_TSG6, which does not have any metal ion binding sites (50))
showed that this domain can interact with rHC1 (both WT and
D298A; Figs. 5C and 6 (B and C)), where this had very similar
binding kinetics to the interaction of rhTSG-6 with the D298A
mutant (Figs. 5D and 6E and Table 2). Thus, we conclude that
full-length TSG-6 can interact with HC1 at two distinct sites: a
metal ion-independent interaction with the Link domain and a
metal ion-dependent interaction with the CUBmodule.
Free TSG-6 and HCTSG-6 Utilize Different HA-binding
Sites—As noted in the introduction the formation of HCHA
results from the covalent transfer of a HC from the HCTSG-6
intermediate onto HA (37). Therefore, it is perhaps not unrea-
sonable to suppose that theHCTSG-6 complex utilizes thewell
characterized HA-binding site present in the Link module of
TSG-6 (see Ref. 45) for its HA recognition during the transfer
process. In order to test this hypothesis, we analyzed three
rhTSG-6 mutants with impaired HA-binding activity (Fig. 7A)
for their ability to form HCTSG-6 complexes and mediate HC
transfer (Fig. 7, B and C); the three mutants have essentially
identical intrinsic fluorescence spectra to the WT rhTSG-6
protein in the absence/presence of reducing and/or denaturing
buffer (data not shown), which is consistent with NMR spec-
troscopy on equivalent mutants in the isolated Link module
showing that they all had WT folds (83).4 D. C. Briggs, C. M. Milner, and A. J. Day, unpublished data.
FIGURE 6. SPR analyses of the interactions of rHC1 with TSG-6. SPR sensorgrams (black lines) for the interactions of immobilized WT CUB_C with WT
rHC1 (A), immobilized WT (B) and D298A (C) rHC1 with Link_TSG6, and immobilized WT (D) and D298A (E) rHC1 with rhTSG-6; concentrations were 5, 10,
20, 25, and 30 nM for WT rHC1 in A and 18.75, 37.5, 75, 150, and 300 nM for analytes in (B–D). Fits from the Langmuir 1:1 model are shown in red. Data are
representative of three independent experiments (see Table 2 for derived numerical values). Despite some apparent biphasic behavior in the interac-
tions, there were no marked improvements in the fits when a bivalent analyte model was applied; moreover, fits with the Langmuir 1:1 model yielded
acceptable 2 values (Table 2), indicating that the derived values represent reasonable estimates of the affinity and kinetics for these interactions. RU,
response units.
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As can be seen from Fig. 7, the Y47F, Y94F, and Y113F
mutants have reduced HA-binding activities (Fig. 7A), but all
retain the ability to formHCTSG-6 complexes (Fig. 7B). How-
ever, whereas Y47F has impaired (but not completely abol-
ished) activity for HC transfer (Fig. 7, B and C), the Y94F and
Y113F mutants are indistinguishable from WT rhTSG-6 in
their formation of HCHA (Fig. 7B). This provides clear evi-
dence that the HA interaction site in the context of the
HCTSG-6 intermediate is not the same as the HA-binding site
in free TSG-6.
The above data also reveal that the Linkmodule of TSG-6 con-
tributes directly to HC transfer because the Y47F mutant has
impaired activity (Fig. 7,B andC). However, the addition of excess
Link_TSG6 protein did not affect the formation of HCTSG-6 or
HCHAcomplexes (Fig. 8A), demonstrating that the isolated Link
module is not an effective competitive inhibitor of HC transfer.
FIGURE 7.Determining the role of TSG-6 amino acids in HCTSG-6 complex formation andHC transfer. A, the HA-binding properties of rhTSG-6WT and three
mutants (Y47F, Y94F, and Y113F) were compared in amicrotiter plate-based assay utilizing biotinylated HA (bHA); data aremean values S.E. (n 8). B, SDS-PAGE
visualization ofHCTSG-6 complex formation (left) andHC transfer (right) assays forWT rhTSG-6 and threemutants (with impairedHA-binding activities); in the latter,
an HA14 oligosaccharide was used as the substrate, leading to the formation of HCHA14 complexes. The gels shown are each representative of three independent
experiments. C, a bHA10 oligosaccharidewas used in transfer assays to compare the activities ofWT andmutant (Y47F, Y94Y, and E183S) rhTSG-6 proteins, allowing
detectionofHCbHA10 complexesonblots (left)made fromgelsequivalent to those shown inB; bandscorresponding toHCbHA10werequantitatedbydensitometry
(right) from three independent experiments (mean S.E. (error bars)).
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HCTSG-6 Complex Formation and HC Transfer Have Dif-
ferent pH Dependences—HC transfer assays conducted at a
range of pH values between pH 4.0 and 8.0 revealed that the pH
dependences for complex formation and HC transfer onto HA
are distinct (Fig. 8B). At pH 6.0, whereas HCTSG-6 complexes
were clearly formed, only very low levels ofHCHAwere detect-
able; neither of these reactions occurred at pH 4.0, and there
was only a faint band observed for the HCTSG-6 complex at
pH5.0.However, at pH6.5 (and above), complex formation and
HC transfer both occur readily. These data indicate that the
individual transesterification reactions that lead to the forma-
tion of the HCTSG-6 intermediate and the HCHA complex
are distinct and probably can be uncoupled. Consistent with
this, we showed previously that the covalent HCTSG-6 com-
plex is stable in the absence of HA for relatively long time peri-
ods (at least 26 h) but that the second transesterification can
proceed once the HA substrate is provided (37).
The HC Transfer Activity of TSG-6 but Not HA Binding Is
Necessary for COC Expansion—In agreement with previous
observations (12), compact COCs isolated from TSG-6/
mice were unable to form an expanded and correctly organized
cumulus matrix (Fig. 9A) (i.e. when stimulated with epidermal
growth factor in vitro and with serum as the source of II).
However, the inclusion of 1 g/ml WT rhTSG-6 protein com-
pletely rescued this phenotype such that TSG-6/ COCs
expanded in an analogous manner to those from TSG-6/
animals (Fig. 9, A and B); the isolated Link module and CUB_C
domains were unable to rescue cumulus expansion (Fig. 9A).
Mutants of rhTSG-6, with differential activities (Fig. 7), were
analyzed in this assay system to determine which functions of
TSG-6 are required to support the formation of the cumulus
extracellular matrix (Fig. 9B). Like WT rhTSG-6, the Y94F
mutant fully rescued COC expansion in a dose-dependent
manner, reaching a maximum effect when added at 1 g/ml
(Fig. 9B). This demonstrates that the HA-binding function of
TSG-6 is not a major requirement for cumulus expansion
because this mutant has greatly impaired HA-binding activity
(Fig. 7A) while retaining both WT HCTSG-6 complex forma-
tion and HC transfer activities (Fig. 7, B and C). The E183S
mutant, which has impaired (but not abolished) ability to form
HCTSG-6 (Fig. 1C) andHCHA (Fig. 7C) complexes, wasmuch
less active thanWT rhTSG-6, only rescuing theTSG-6/ phe-
notype when added at 10 g/ml. The Y47F mutant had lower
activity still, only partially rescuing expansion at the highest
concentration tested (Fig. 9B); this mutant has defective HA
binding and impaired HC transfer activity while retaining the
ability to form the HCTSG-6 complex (Fig. 7). Overall, the
above data indicate that TSG-6-mediated formation of HCHA
complexes (via HCTSG-6 intermediates) is critical for the for-
mation of the cumulusmatrix, whereas theHA-binding activity
of TSG-6 in the context of the free protein does not contribute
greatly to this process.
Discussion
Here, through combined structural and biophysical ap-
proaches, we have determined the role of metal ions in the
formation of covalent HCTSG-6 complexes that act as inter-
mediates in HC transfer onto HA. We have also found that
although the TSG-6-mediated formation of HCHA complexes
is essential for the expansion of mouse COCs in vitro, the HA-
binding function of TSG-6 does not play a major role in the
stabilization of the murine cumulus matrix.
As illustrated in Fig. 10, HCTSG-6 complex formation is a
divalent cation-dependent reaction (37, 40), which our data
reveal is mediated by Ca2, bound to a site within the TSG-6
CUBmodule. The Glu-183 residue, which is involved in chelat-
ing the Ca2 ion, makes a major contribution to the non-cova-
lent interaction with HCs of II (e.g. via their Mg2-containing
MIDAS motifs), which precedes formation of the covalent
bond between TSG-6 and HC. Tyr-47 in the Link module of
TSG-6 then contributes to HA recognition by the HCTSG-6
complex during “HC transfer,” but other residues implicated
previously in HA binding in free TSG-6 (Tyr-94 and Tyr-113)
are not involved in this process.
From the results presented here, it is apparent that Ca2 ion
binding is not necessary for the CUBmodule to fold, but rather
it plays a role in providing local structural organization (Figs. 1
and 3) (e.g. of surrounding loops). In particular, it probably ori-
ents the functionally important Glu-183 amino acid residue,
allowing it to interact with the HC. In this regard, our recent
crystal studies on human HC1 have revealed that its von Will-
ebrand factor A domain contains a Mg2-containing MIDAS
motif, where mutation of the chelating Asp-298 residue abol-
ishes metal ion binding without having any effect on the overall
FIGURE 8. Role of TSG-6 Link module in HA recognition and pH depen-
dence of complex formation and HC transfer. A, SDS-PAGE analysis of HC
transfer assays (with HA14 as substrate) in the presence of different molar
ratios of Link_TSG6 to rhTSG-6 (at its standard concentration); the gel shown
is representative of three independent experiments. B, SDS-PAGE analysis of
HC transfer assays conducted under different pH conditions with HA14 as
substrate. These data are representative of three independent experiments.
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structure.4 As shown here, the D298A mutant of rHC1 also
abolishes binding to the TSG-6 CUB_C domain (Table 2), pro-
viding compelling evidence that this Mg2 ion has a critical
function in HCTSG-6 formation. These findings suggest the
intriguing possibility that the metal ion-dependent interaction
of TSG-6 with II may be mediated by the Glu-183 side chain
carboxylate (of the CUB module) co-chelating the magnesium
ion within the MIDAS of the HC (i.e. reminiscent of interac-
tions between von Willebrand factor A domains of integrins
and their RGD-containing ligands (90)).
The discovery that TSG-6 has a Ca2 ion-binding site
explains why previously we found it unnecessary to add any
calcium to formHCTSG-6 and HCHA complexes in vitro (37,
45). This is because the rhTSG-6 used in these assays already
contained calcium (i.e. based on “as purified” CUB_C being
fully calcium ion-bound) (Fig. 3). Other studies did, however,
indicate a requirement of Ca2 for complex formation and HC
transfer (41, 42). In our assay system, the addition ofMg2 ions
is required when we are using preparations of II where metal
ions have been removed during purification (83). Importantly,
differences in the sources of protein reagents and assay condi-
tions probably explain the lack of consistency in the conclu-
sions reached previously on the role of metal ions in the forma-
tion of HCTSG-6 and HCHA (37, 40–42).
Our interaction analyses described here indicate that the
full-length TSG-6 can interact with HC1 at two distinct sites: a
metal ion-independent interaction with the Link domain and a
metal ion-dependent interaction with the CUBmodule (Fig. 5).
Interestingly, both interactions have Kd values of2 nM (Table
2), which is very similar to the affinity (5 nM) for the interac-
tion of rhTSG-6 with rHC1 and rHC2 (44). Therefore, it seems
unlikely that simultaneous binding of the CUB and Link mod-
ules to HCs can occur (because the affinity for rhTSG-6 would
then be considerably higher). In this regard, it is reasonable to
FIGURE 9.TSG-6HC transfer activity rather than itsHAbinding functionplays a critical role in cumulus expansion.A, COCs from TSG-6/mice undergo
cumulus expansion (over 16 h) when stimulated in vitrowith EGF, but TSG-6/ COCs do not expand, and cumulus cells are shed and settle on the plastic dish.
The rhTSG-6 protein (1g/ml), but not Link_TSG6 or CUB_C (CUB_C_TSG6) (also both at 1g/ml), was able to rescue expansion of TSG-6/ COCs. These data
are representative of two independent experiments. B, expansion of TSG-6/ COCs was completely rescued by the addition of 1g/ml WT or Y94F rhTSG-6.
Y47F and E183Sonly had effects at the highest concentration tested (10g/ml), where theymediatedpartial or complete rescue, respectively. Thedata shown
are representative of three independent experiments.
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suggest that of these it is the CUB-mediated (Ca2 ion- and
Glu-183-dependent) interaction that is critical for HCTSG-6
complex formation, given the evidence supporting the role of
divalent cations (37, 40–41) and Glu-183 (Figs. 1 and 4A) in
this process. On the other hand, the interactionwithHC via the
TSG-6 Link module might provide a mechanism whereby
HCTSG-6 complexes can remain bound to HCHA and play a
role in further catalysis of HC transfer, as suggested previously
(44).
TSG-6 can also bindweakly (180 nM) andmetal ion-indepen-
dently to the bikuninCS component of II (40, 46); this is prob-
ably mediated (at least in part) through the recognition of the
CS chain by the Link module (47). Interestingly, this CSmoiety
has been clearly implicated as being necessary for HCTSG-6
formation (40), requiring a particular sulfation pattern in the
glycosaminoglycan linkage region in order for II to act as a
substrate (24); chondroitin (91, 92) and the CS chain of
bikuninCS (93), which has non-sulfated “chondroitin-like”
regions (23), can act as weak substrates for HC transfer. At the
moment, we do not know the temporal sequence of this
CSbikunin-binding event relative to the metal ion-dependent
interaction between the TSG-6 CUB module and an II HC
(described in the present study). What seems certain is that
these interactions are precisely coordinated in such a way as to
correctly orient the TSG-6 molecule relative to II so that the
ester bond connecting anHC to theCS chain can be transferred
onto Ser-28 of TSG-6 (39). The fact that HC1TSG-6 and
HC2TSG-6 complexes form in essentially equal amounts (37,
38) suggests a stochastic element to the process. A plausible
mechanism would be for an initial Link module-mediated
interaction between the TSG-6 and bikuninCS, followed by a
random “molecular collision” between the Glu-183 of the
TSG-6 CUB module and the MIDAS of either HC1 or HC2.
This would probably lead to a short lived, high affinity, inter-
mediate involving both interactions, which is destabilized once
the HCCS bond has been transferred onto TSG-6 and the
bikuninCS by-product (37, 38) is released.
Regardless of the precise sequence of the interactions, the
non-covalent HCTSG-6 complex formed must position the
Ser-28 side chain of TSG-6 and the HCCS ester bond in close
proximity to the catalytic site, allowing the covalent HCTSG-6
complex to form via a transesterification reaction (39). How-
ever, currently, we do not know where the enzyme active site is
located. Our analyses of the pH dependences of complex for-
mation and HC transfer suggest that a histidine (which usually
has pKa values between6.0 and 6.5) is involved in both reac-
tions (Fig. 8B); this functional residue(s) is likely to be present in
TSG-6, given its role as the catalyst ofHCHA formation (37). In
this regard, we observed that residues Asp-200 and His-203 of
TSG-6 adopt relative conformations reminiscent of Asp-His-
Ser catalytic triads within the CUB module structure, and the
propKa software (94, 95) predicted that the pKa of His-203
might be elevated, as is the case for serine proteases (96). How-
ever, the H203S mutant of rhTSG-6 was found to have WT
activity for HCTSG-6 complex formation and HC transfer
(data not shown), ruling out a role for this amino acid. System-
atic mutagenesis will be required to determine whether a histi-
dine residue of TSG-6 does form part of the catalytic site.
Somewhat counterintuitively, we have found that the HA-
binding site in “free” TSG-6 is not the same as that used for HA
recognition in the context of HC transfer; this was based on a
lack of correlation between the abilities of rhTSG-6 mutants to
interact with HA and to form HCHA complexes (Fig. 7). Fur-
thermore, the observation that the Link_TSG6protein does not
inhibit HCHA formation (Fig. 8A) provided further evidence
that the HA-binding site in free TSG-6 is not utilized for HA
recognition by HCTSG-6. This conclusion is consistent with
our recent studies showing that there was also no correlation
between the substrate activities of various HA oligosaccharides
in transfer assays and their affinities for Link_TSG6 (45).More-
over, our previous biophysical experiments have revealed that
the interaction of TSG-6 with II and the formation of
HCTSG-6 inhibit the binding of TSG-6 to HA, reversing TSG-
6-mediated cross-linking of HA (44).
It is noteworthy that the Tyr-47 and Tyr-94 residues are
located close together within the HA-binding groove of the
TSG-6 Link module (45, 49), yet despite their proximity (7 Å
between hydroxyl oxygens, based on x-ray structure (50)) and
the similar (greatly reduced) HA-binding phenotype of their
phenylalanine mutants (Fig. 7A), they exhibit markedly differ-
ent contributions to HC transfer activity (Fig. 7, B and C). This
could be explained by the formation of a composite HA recog-
nition site involving both TSG-6 and HCwithin the HCTSG-6
complex, in which Tyr-47, but not Tyr-94 or Tyr-113, of TSG-6
plays a role (i.e.whereHCprobably occludes part of the binding
surface used for HA in free TSG-6).
FIGURE 10. Schematic model of the metal ion-dependent interaction of
TSG-6 with II, leading to the formation of HCHA complexes via an
HCTSG-6 intermediate. i, the CUB_C domain of TSG-6 interacts via its Glu-
183 residue (red space filling) with theMIDAS site (*) of the HCs (illustrated for
HC1) in a metal ion-dependent manner, leading to the formation of an initial
non-covalent HCTSG-6 complex. The Glu-183 amino acid conformation (and
the surrounding structure) is stabilizedby thepresenceof boundCa2, which
is essential for the interaction with HCs. ii, the non-covalent HCTSG-6 com-
plex then converts to a covalent complex via the formation of an ester bond
(red) between Ser-28 of TSG-6 (green space filling) and the C-terminal aspartic
acid residue of an HC (39). HA is recognized (yellow arrow) by a composite
surface involving Tyr-47 of the TSG-6 Link module (pink) and residues of the
HC, leading to the covalent transfer of the HC from TSG-6 onto HA. Previous
studies have demonstrated that HC transfer is a divalent cation-dependent
process (37), and therefore it is likely to involve the metal ion-dependent
interaction in i to stabilize the enzyme complex. iii, formation of HCHA leads
to release of TSG-6 (not shown), which can then interact with a new II mol-
ecule and catalyze the formation of further HCHA.
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Given that HCTSG-6 (unlike free TSG-6) does not bind
tightly to HA (44), it seems plausible that during HC transfer,
there is only a transient “interaction” of HA with the active site
of this enzyme complex. It seems likely that residues from both
TSG-6 and HC contribute to a composite active site (including
a histidine, as discussed earlier) that is stabilized by the Glu-
183- and Ca2-dependent interaction of the CUBmodule with
the MIDAS site of the HC (i.e. based on the requirement for
divalent cations in the transfer of HC ontoHA (37)). This active
site is probably similar to that used in the initial transesterifica-
tion reaction (i.e.within the non-covalentHCTSG-6 complex).
However, it is clearly not identical, as can be inferred from the
different pH minima of the two reactions (Fig. 8B); this is to be
expected because the formation of HCHAhas a different spec-
ificity requirement, with the transfer of the ester bond onto the
C6hydroxyl ofHA (28) rather than onto the side chain hydroxyl
of Ser-28 (39).
Here we have demonstrated that the TSG-6-dependent
transfer ofHContoHA is an absolute requirement for the orga-
nization/stabilization of the cumulus matrix, whereas the HA-
binding properties of TSG-6 do not play an important role (i.e.
based on the ability of rhTSG-6 mutants to rescue in vitro
expansion of COCs from TSG-6/ mice) (Fig. 9). These data
are consistent with previous studies showing the involvement
of HCHA in COC expansion (9, 12, 13, 91), where the forma-
tion of these complexes is mediated by TSG-6 (37, 39, 40). Fur-
thermore, the present study indicates that TSG-6 is not amajor
participant in the structural stabilization of the cumulusmatrix
through its direct cross-linking of HA chains, as has been sug-
gested previously (12, 13, 15, 31, 34, 53, 54). This is perhaps not
surprising, given the recent findings that the interaction of
TSG-6 with II impairs the binding of TSG-6 to HA (44) and
that the full-length TSG-6 protein is unable to bridge between
pentraxin-3 and HA (16), although this is a property of its iso-
lated Link module domain (15, 16). Moreover, our recent bio-
physical studies have provided strong evidence that TSG-6, II,
and pentraxin-3 cooperate to cross-link HA (16), where multi-
ple HCHA complexes probably associate with the octamer
pentraxin-3 (31–33). However, this cross-linking process is
tightly regulated, and, surprisingly, pentraxin-3 does not inte-
grate into preformedHCHA films but requires a prior encoun-
ter with II (16). Why this should be the case is unclear, indi-
cating that there is still much we do not understand regarding
how the process of COC expansion is controlled (both tempo-
rally and spatially) and the way that these proteins organize HA
in the cumulus matrix. In this regard, it seems probable that as
well as the association of HCHA with pentraxin-3, there are
likely to be other interactions that play a role in stabilizing the
HA network. Interestingly, the finding that the Y47Fmutant of
rhTSG-6 has the most impaired rescue activity (Fig. 9B),
although it retains more HC transfer activity than E183S (Fig.
7C), is indicative that TSG-6 does play an additional role in
COC expansion besides its catalysis of HCHA formation.
This research has provided important new insights into the
mechanisms underlying TSG-6-mediated HCHA formation
and has clarified the role of divalent metal ions in this funda-
mental biological process. It has also identified that it is the
transferase activity of TSG-6 that is essential for COC expan-
sion rather than its HA-binding function. These studies there-
fore provide an excellent basis for additional work to further
understand the molecular basis of HA cross-linking during
ovulation and inflammation.
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